Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 5/2001

Inhalt (6 Artikel)

ORIGINAL ARTICLE

Th1-cytokine induction and anti-tumor effect of 55 kDa protein isolated from Aeginetia indica L., a parasitic plant

Go Ohe, Masato Okamoto, Tetsuya Oshikawa, Sachiko Furuichi, Hidetomo Nishikawa, Tomoyuki Tano, Kayo Uyama, Takashi Bando, Hideo Yoshida, Toru Sakai, Kunisuke Himeno, Mitsunobu Sato, Shinya Ohkubo

ORIGINAL ARTICLE

Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions

Kazuyasu Nakamura, Yuko Tanaka, Kenya Shitara, Nobuo Hanai

ORIGINAL ARTICLE

Renal carcinoma cell lines inhibit natural killer activity via the CD94 receptor molecule

Anthea J. Stanley, Michael J. Gough, Rosamonde E. Banks, Peter J. Selby, Poulam M. Patel

ORIGINAL ARTICLE

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

Barbara E. Power, Joanne M. Caine, John E. Burns, Deborah R. Shapira, Meghan K. Hattarki, Kiki Tahtis, F.-T. Lee, Fiona E. Smyth, Andrew M. Scott, Alexander A. Kortt, Peter J. Hudson

ORIGINAL ARTICLE

Comparative analysis of IFN-γ B7.1 and antisense TGF-β gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma

Rita S. Wu, James J. Kobie, David G. Besselsen, Tim C. Fong, Vivian D. Mack, Julie A. McEarchern, Emmanuel T. Akporiaye

ORIGINAL ARTICLE

Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial

Harry D. Bear, John Roberts, David Cornell, Mary Beth Tombes, Brenda Kyle

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.